Decibel Therapeutics and Invitae Launch Amplify Testing

Decibel Therapeutics announced a partnership with Invitae, a medical genetics company, to launch Amplify, a no-charge genetic testing program to screen for the genetic cause of congenital hearing loss in children diagnosed with auditory neuropathy.